TRML

COM:TOURMALINEBIO

Tourmaline Bio, Inc.

  • Stock

Last Close

24.00

21/11 21:00

Market Cap

352.13M

Beta: -

Volume Today

188.79K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
net income
-12.94M
-
-14.24M
10.05%
-264
100.00%
-12.56K
4,658.33%
-1.96K
84.44%
-4.92K
151.66%
-7.50M
152,379.67%
-16.13M
115.00%
-20.62M
27.84%
2.13M
110.31%
-13.31M
726.11%
-20.18M
-
depreciation and amortization
167K
-
188K
12.57%
1
-
5
400%
6K
119,900%
7K
16.67%
1.13M
15,971.43%
-1.10M
198.22%
10K
100.90%
10K
-
deferred income tax
stock based compensation
195
-
393K
201,438.46%
416K
5.85%
5.27M
1,167.31%
-312K
105.92%
1.39M
544.87%
416K
70.03%
3.07M
637.41%
change in working capital
1.52M
-
3.21M
111.94%
52
100.00%
-185
455.77%
787
525.41%
55
93.01%
3.28M
5,963,536.36%
-2.70M
182.41%
-2.45M
9.36%
1.71M
169.59%
-1.81M
206.16%
1.84M
-
accounts receivables
inventory
accounts payables
-287K
-
1.11M
487.80%
3.02M
-
-2.22M
173.43%
-4.43M
99.82%
3.58M
180.89%
866K
75.82%
-333K
-
other working capital
1.80M
-
2.10M
16.47%
52
100.00%
-185
455.77%
787
525.41%
55
93.01%
262
376.36%
-487
285.88%
-296
39.22%
397
234.12%
-2.68K
774.06%
485.68K
-
other non cash items
1.75M
-
273K
84.40%
62
99.98%
12.23K
19,629.03%
-129
101.05%
168
230.23%
32K
18,947.62%
8.87M
27,612.50%
-224
100.00%
-1.11K
396.88%
35K
3,244.65%
-8.19M
-
net cash provided by operating activities
-10.13M
-
-9.83M
2.95%
-150
100.00%
-515
243.33%
-1.30K
151.65%
-4.50K
246.99%
-3.79M
84,200.64%
-9.54M
151.68%
-25.77M
170.10%
11.02M
142.77%
-14.92M
235.41%
-23.44M
-
investments in property plant and equipment
-726K
-
-1.19M
63.77%
-13
-
-2.29M
17,646,053.85%
-24K
98.95%
-13K
45.83%
-504K
3,776.92%
-2
100.00%
acquisitions net
purchases of investments
-35.95M
-
-65.09M
81.08%
68.55M
-
-215.87M
414.91%
-88.05M
-
sales maturities of investments
38.37M
-
67M
74.64%
-156.80M
-
27M
117.22%
76.35M
-
other investing activites
-5K
-
3.90K
-
-188.87K
4,947.77%
net cash used for investing activites
1.69M
-
721K
57.44%
-5K
-
-13
99.74%
-55
323.08%
-24K
43,536.36%
-13K
45.83%
92.30M
710,061.54%
-88.42M
195.80%
-188.87M
113.61%
-11.70M
-
debt repayment
common stock issued
-551K
-
412K
174.77%
161.35M
-
common stock repurchased
dividends paid
other financing activites
19.85K
-
92.20K
-
-3.62K
103.93%
68.14K
1,980.82%
161.35K
136.79%
-1K
-
net cash used provided by financing activities
-551K
-
412K
174.77%
19.85K
-
92.20M
-
-91.94M
199.72%
156.46M
270.17%
161.35M
3.12%
-1K
-
effect of forex changes on cash
net change in cash
-8.99M
-
-8.70M
3.22%
-150
100.00%
14.34K
9,656.67%
-1.31K
109.13%
-4.55K
247.75%
-3.81M
83,709.31%
82.65M
2,266.37%
-20.22M
124.47%
73.87M
465.28%
-42.44M
157.45%
-34.91M
-
cash at beginning of period
36.30M
-
27.31M
24.76%
14.34K
-
13.03K
9.13%
8.47M
64,954.51%
4.66M
45.02%
87.31M
1,773.92%
67.08M
23.16%
140.95M
110.12%
70.15M
-
cash at end of period
27.31M
-
18.61M
31.84%
-150
100.00%
14.34K
9,656.67%
13.03K
9.13%
8.47K
34.95%
4.66M
54,879.94%
87.31M
1,773.92%
67.08M
23.16%
140.95M
110.12%
98.51M
30.11%
35.23M
-
operating cash flow
-10.13M
-
-9.83M
2.95%
-150
100.00%
-515
243.33%
-1.30K
151.65%
-4.50K
246.99%
-3.79M
84,200.64%
-9.54M
151.68%
-25.77M
170.10%
11.02M
142.77%
-14.92M
235.41%
-23.44M
-
capital expenditure
-726K
-
-1.19M
63.77%
-13
-
-2.29M
17,646,053.85%
-24K
98.95%
-13K
45.83%
-504K
3,776.92%
-2
100.00%
free cash flow
-10.86M
-
-11.02M
1.51%
-150
100.00%
-515
243.33%
-1.31K
154.17%
-2.30M
175,491.83%
-3.81M
65.98%
-9.55M
150.43%
-26.27M
175.01%
11.02M
141.95%
-14.92M
235.41%
-23.44M
-

All numbers in (except ratios and percentages)